home / stock / enlv / enlv quote
Last: | $ |
---|---|
Change Percent: | 6.59% |
Open: | $8.35 |
Close: | $8.74 |
High: | $8.74 |
Low: | $8.231 |
Volume: | 5,431 |
Last Trade Date Time: | 02/12/2020 04:40:51 pm |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$ | $8.35 | $8.74 | $8.74 | $8.231 | 5,431 | 02-12-2020 |
$ | $8.60 | $8.20 | $8.60 | $8.00 | 8,670 | 02-11-2020 |
$ | $8.08 | $8.26 | $8.54 | $8.08 | 24,912 | 02-10-2020 |
$ | $7.6101 | $7.75 | $7.75 | $7.6101 | 4,351 | 02-07-2020 |
$ | $7.29 | $7.7108 | $7.79 | $7.29 | 9,029 | 02-06-2020 |
$ | $7.46 | $6.88 | $7.8724 | $6.88 | 28,396 | 02-05-2020 |
$ | $7.90 | $7.57 | $7.96 | $7.50 | 19,929 | 02-04-2020 |
$ | $7.65 | $7.70 | $7.7385 | $7.65 | 3,756 | 02-03-2020 |
$ | $8.11 | $7.99 | $8.15 | $7.54 | 3,719 | 01-31-2020 |
$ | $8.10 | $8.16 | $8.43 | $8.10 | 6,956 | 01-30-2020 |
$ | $8.63 | $8.30 | $8.6396 | $8.30 | 5,781 | 01-29-2020 |
$ | $8.57 | $8.98 | $8.98 | $8.3114 | 2,070 | 01-28-2020 |
$ | $8.38 | $8.51 | $8.5701 | $8.22 | 15,643 | 01-27-2020 |
$ | $9.70 | $9.0952 | $9.70 | $9.05 | 4,211 | 01-24-2020 |
$ | $9.88 | $9.91 | $9.91 | $9.50 | 3,375 | 01-23-2020 |
$ | $9.35 | $9.81 | $10.00 | $9.35 | 19,497 | 01-22-2020 |
$ | $9.05 | $9.056 | $9.15 | $8.92 | 18,140 | 01-21-2020 |
$ | $8.54 | $8.928 | $8.9552 | $8.54 | 29,088 | 01-20-2020 |
$ | $8.54 | $8.928 | $8.9552 | $8.54 | 29,088 | 01-17-2020 |
$ | $8.92 | $8.54 | $8.92 | $8.54 | 27,969 | 01-16-2020 |
News, Short Squeeze, Breakout and More Instantly...
Enlivex Therapeutics Ltd. Company Name:
ENLV Stock Symbol:
NYSE Market:
Enlivex Therapeutics Ltd. Website:
First patient dosed with Allocetra TM in thumb osteoarthritis, a degenerative, debilitating and progressive disease that affects millions of people Thumb osteoarthritis currently has no FDA-approved therapy and no effective long-term treatments Ness-Ziona, Israel, June 24, 2024 (GLO...
Ness-Ziona, Israel, June 20, 2024 (GLOBE NEWSWIRE) -- Enlivex Therapeutics Ltd. (Nasdaq: ENLV, the “Company” or “Enlivex”), a clinical-stage macrophage reprogramming immunotherapy company, is pleased to invite investors to a webinar on June 25, 2024, at 4:15 p.m...
Key Highlights Enrolled patients with severe knee osteoarthritis who were indicated for knee-replacement surgery received a single local injection of Allocetra TM into the knee as a “last resort” Three-month data readout showed a significant reduction in pain and a f...